Heterovesicular liposomes

Details Heterovesicular liposomes Heterovesicular liposomes

1993-06-16

1995-06-06

Kishore, Gollamudi S.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

264 41, 264 43, 264 46, 436829, A61K 9127, B01J 1302

Patent

active

054221200

ABSTRACT:
Disclosed are heterovesicular liposomes containing substances of different biologically active compositions each encapsulated in separate chambers of the liposomes, having defined size distribution, adjustable average size, adjustable internal chamber size and number, methods of making them, and treatment of patients with them.

REFERENCES:
patent: 4078052 (1978-03-01), Papahadjopoulos
patent: 4089801 (1978-05-01), Schneider
patent: 4145410 (1979-05-01), Sears
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos
patent: 4310506 (1982-01-01), Baldeschwieler et al.
patent: 4394372 (1983-07-01), Taylor
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4752425 (1988-07-01), Martin et al.
patent: 4769250 (1988-09-01), Forssen
patent: 4781871 (1988-11-01), West, III et al.
patent: 4920016 (1990-04-01), Allen et al.
patent: 5000959 (1991-03-01), Iga et al.
patent: 5021200 (1991-06-01), Vanlerberghe et al.
patent: 5077056 (1991-12-01), Bally et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5211955 (1993-05-01), Legros et al.
Kim, Prep. of Multivesicular Liposomes, BBA, 728, 339 (1983).
CA 107(10) 83830x, 1987, Kim.
Fidler, Drug Carrier Systems, Ed. by Roerdink & Kim, p. 213 (1989).
Huang, Biochemistry, 8:334-352, 1969, "Studies on Phosphatidylcholine Vesicles Formation and Physical Characteristics".
Bang, M., Mol. Bio., 13-238-252, 1965, "Diffusion of univalent ions across the lamellae of swollen phospholipids".
Szoka, et al., Ann. Rev. Biophys. Bioeng., 9:465-508, 1980, "Comparative properties and methods of preparation of lipid vesicles (liposomes)".
Shakiba, et al., Investigative Ophthalmology and Visual Science, 34(10):2903-10, 1993 Sep., "Evaluation of retinal toxicity and liposome encapsulation of the Anti-CMV Drug 2'-nor-cyclic GMP".
Frucht-Perry, et al., Cornea, 11(5):393-7, 1992 Sep., "Fibrin-enmeshed tobramycin liposomes: single application topical therapy of pseudomonas . . . ".
Assil, et al., Investigative Ophthalmology and Visual Science, 32(13):3216-20, 1991 Dec., "Tobramycin liposomes. Single subconjunctival therapy of . . . ".
Assil, et al., Investigative Ophthalmology and Visual Science, 32(11):2891-7, 1991 Oct., "Liposome suppression of proliferative vitreoretinopathy. Rabbit . . . ".
Turski, et al., Magnetic Resonance in Medicine, 7(2):184-96, 1988 Jun., "Magnetic resonance imaging of rabbit brain after intracarotid injection . . . ".
Skuta, et al., American Journal of Ophthalmology, 103(5):714-16, 1987, May 15, "Filtering surgery in owl monkeys treated with the antimetabolite . . . ".
Assil, et al., Archives of Ophthalmology, 105(3):400-3, 1987 Mar., "Multivesicular liposomes. Sustained release of the antimetabolite . . . ".
Barbet, et al., Biochimica et Biophysica Acta, 772(3):347-56, 1984, May 30, "Weat acid-induced release of liposome-encapsulated carboxyfluorescein".
Kim., et al., Biochim. Biophys. Acta, 646:1, 1981, "Preparation of cell-size unilamellar liposomes with high captured volume and defined size . . . ".
Kim, et al., Biochim. Biophys. Acta, 728:339-348, 1983, "Preparation of multivesicular liposomes".
Kim., et al., Biochim. Biophys. Acta, 793:801, 1985, "Preparation of multilamellar vesicles of define size-distribution by solvent-spherule . . . ".
Kim., et al., Cancer Treat. Rep., 71:705-711, 1987, "Multivesicular liposomes containing cytarabine entrapped in the presence of . . . ".
Kim., et al., Cancer Research, 47:3935-3937, 1987, "Mutlivesicular Liposomes Containing cytosine arabinoside for slow-release intrathecal therapy".
Kim, et al., Cancer Treat Rep., 71:447-450, 1987, "Multivesicular liposomes containing cytosine arabinoside for slow-release . . . ".
Kim et al., Cancer Chemother Pharmacology, 19:307-310, 1987, "Modulation of the peritoneal clearance of liposomal ara-C by blank liposomes".
Roy, et al., Cancer Cherother. Pharm., 28:105-108, 1991, "Multivesicular liposomes containing bleomycin for subcutaneous administration".
Kim, et al., Reg. Cancer Treat., 2:170-173, 1989, "Intratumoral chemotherapy with multivesicular liposomes containing 1-b-D-arabino . . . ".
Kim, et al., J. Inf. Dis., 162:750-752, 1990, "Multivesicular liposomes for CSF delivery of retroviral agent DDC".
Chamberlain, et al., Archives of Neurol, 50(3):261-264, 1993, "Treatment of leptomeningeal metastasis with intraventricular administration of . . . ".
Chatlut, et al., Cancer Them. Pharmacol., 32:179-182, 1993, "A slow-release methotrexate formation for inrathecal chemotherapy".
Russack, et al., Ann. Neurol., 34:108-112, 1993, "Quantitative cerebrospinal fluid cytology in patients receiving intracavitary chemotherapy".
Kim, et al., J. Clin. Oncol., 11:2186-2193, 1993, "Extended cerebrospinal-fluid cytarabine exposure following intrathecal administration of DTC 101".
Kim, Drugs, 46:618-638, 1993, "Liposomes as carriers of cancer chemotherapy: a review".
Kim, Kim, Kim, Cancer Chemother. Pharmacol., 33:187-190, 1993, "Extended-release formulation of morphine for subcutaneous administration".
Ishii, Liposome Technology, 1:111-121, 1993, "Production and Size Control of Large Unilamellear Liposomes by Emulsification".
Cullis, et al., Phospholipids and Cellular Regulation, 1:65-123, 1985, "Structural properties and functional roles of phospholipids in . . . ".
Bonetti, et al., Cancer Chemotherapy and Pharmacology, In Press, 1993, "An extended-release formulation of methotrexate for subcutaneous . . . ".
Kim, et al., Cancer Res., 53:1596-1598, 1993, "Prolongation of drug action in CSF by encapsulation into multivescicular liposomes".

Affiliated with

Also associated with

Rating

Heterovesicular liposomes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterovesicular liposomes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterovesicular liposomes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-985865